Unit of Oral Medicine and Pathology, ASST dei Sette Laghi-Ospedale di Circolo e Fondazione Macchi, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Laboratory of Clinical Microbiology, ASST dei Sette Laghi-Ospedale di Circolo e Fondazione Macchi, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
J Dent Res. 2021 Feb;100(2):115-123. doi: 10.1177/0022034520969670. Epub 2020 Oct 31.
The diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection relies on the detection of viral RNA by real-time reverse transcription polymerase chain reaction (rRT-PCR) performed with respiratory specimens, especially nasopharyngeal swabs. However, this procedure requires specialized medical personnel, centralized laboratory facilities, and time to provide results (from several hours up to 1 d). In addition, there is a non-negligible risk of viral transmission for the operator who performs the procedure. For these reasons, several studies have suggested the use of other body fluids, including saliva, for the detection of SARS-CoV-2. The use of saliva as a diagnostic specimen has numerous advantages: it is easily self-collected by the patient with almost no discomfort, it does not require specialized health care personnel for its management, and it reduces the risks for the operator. In the past few months, several scientific papers, media, and companies have announced the development of new salivary tests to detect SARS-CoV-2 infection. Posterior oropharyngeal saliva should be distinguished from oral saliva, since the former is a part of respiratory secretions, while the latter is produced by the salivary glands, which are outside the respiratory tract. Saliva can be analyzed through standard (rRT-PCR) or rapid molecular biology tests (direct rRT-PCR without extraction), although, in a hospital setting, these procedures may be performed only in addition to nasopharyngeal swabs to minimize the incidence of false-negative results. Conversely, the promising role of saliva in the diagnosis of SARS-CoV-2 infection is highlighted by the emergence of point-of-care technologies and, most important, point-of-need devices. Indeed, these devices can be directly used in workplaces, airports, schools, cinemas, and shopping centers. An example is the recently described Rapid Salivary Test, an antigen test based on the lateral flow assay, which detects the presence of the virus by identifying the spike protein in the saliva within a few minutes.
严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染的诊断依赖于使用呼吸道标本,尤其是鼻咽拭子,通过实时逆转录聚合酶链反应(rRT-PCR)检测病毒 RNA。然而,该程序需要专业医疗人员、集中式实验室设施和时间来提供结果(从数小时到 1 天不等)。此外,进行该程序的操作人员存在不可忽视的病毒传播风险。出于这些原因,一些研究提出使用其他体液,包括唾液,来检测 SARS-CoV-2。使用唾液作为诊断标本有许多优点:患者几乎没有不适感,可自行采集,无需专业医疗人员进行管理,可降低操作人员的风险。在过去的几个月里,一些科学论文、媒体和公司宣布开发了新的唾液检测方法来检测 SARS-CoV-2 感染。咽后唾液应与口腔唾液区分开来,因为前者是呼吸道分泌物的一部分,而后者是由唾液腺产生的,唾液腺位于呼吸道之外。唾液可以通过标准(rRT-PCR)或快速分子生物学检测(直接 rRT-PCR 无需提取)进行分析,尽管在医院环境中,这些程序可能仅与鼻咽拭子一起进行,以尽量减少假阴性结果的发生。相反,唾液在 SARS-CoV-2 感染诊断中的有前景的作用突出表现在即时检测技术的出现上,最重要的是,即时检测设备的出现。事实上,这些设备可以直接在工作场所、机场、学校、电影院和购物中心使用。最近描述的快速唾液检测就是一个例子,这是一种基于侧向流动分析的抗原检测,通过在几分钟内识别唾液中的病毒刺突蛋白来检测病毒的存在。